Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-22-036714
Filing Date
2022-12-28
Accepted
2022-12-28 20:39:32
Documents
2
Period of Report
2022-12-28

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 3015
2 ex24.htm EX-24 8314
  Complete submission text file 0001493152-22-036714.txt   12688
Mailing Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024
Business Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024 650.739.3939
Coya Therapeutics, Inc. (Issuer) CIK: 0001835022 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PROTHENA BIOSCIENCES INC 331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address
Garren Hideki (Reporting) CIK: 0001854126 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41583 | Film No.: 221496129